The VRBPAC committee will meet in open session on June 14, 2022 to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age. FDA intends to make background material available to the public no later than
The VRBPAC will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of
Discover the latest achievements in the fight against the pneumococcus at the ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases 19-23 June 2022 in Toronto. This meeting was originally scheduled for Oct 2020. Given on-going safety concerns for in-person meetings due to COVID-19 during 2020-2021, the in-person event was ultimately pushed to June 2022. The
The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on
The purpose of this meeting is to gather feedback from stakeholders about their experiences implementing these policies, the effect of these policies in terms of achieving their stated goals, the overarching definition of DURC, and possible alternative approaches for the oversight and responsible conduct of DURC. This feedback will also be used to inform the
TOXINS 2022 will be held July 27-30, 2022, at the New Orleans Marriott in New Orleans, Louisiana. This is the foremost gathering for the latest developments in the basic science and clinical applications of botulinum and other neurotoxins. The scientific program—presented by the world’s experts in their respective fields—will be of interest to basic scientists
The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop on August 30, 2022. All meeting materials—including agenda, panelist affiliations/disclosures, speaker slides, workshop recording, and transcript—will be posted here shortly before and/or after the completion of the workshop. The current state of development of pathogen-directed
Discuss the current landscape of Monkeypox in the U.S and infection prevention considerations for evaluation and management in healthcare settings. Describe the clinical presentation in ambulatory and inpatient settings, as well as the role of supportive and antiviral treatments. This NETEC webinar series presentation will bring together health care practitioners from Massachusetts General Hospital, Cedars-Sinai,
The 21st Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) public meeting is tentatively being planned as an in-person event on September 12 and September 13, 2022. The meeting will focus on pandemic preparedness and AMR policy. Highlighted topics include: Understanding the Human Diagnostic Communication Network (Labs, Public Health Departments, and Providers) Infection Prevention
